Any feedback?
Literature summary extracted from
- 4-Hydroxy-3-(naphthalen-1-ylmethyl)thiophen-2(5H)-one as inhibitors of tyrosyl-tRNA synthase Synthesis, molecular docking and antibacterial evaluation (2014), J. Mol. Struct., 1056-1057, 104-109 .
No PubMed abstract available
Cloned(Commentary)
| EC Number | Cloned (Comment) | Organism |
|---|---|---|
| 6.1.1.1 | recombinant overexpression in Escherichia coli | Staphylococcus aureus |
Inhibitors
| EC Number | Inhibitors | Comment | Organism | Structure |
|---|---|---|---|---|
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 2-bromobenzoate | - |
Staphylococcus aureus |  |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 2-chlorobenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 2-chloropyridine-3-carboxylate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 2-fluorobenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 2-methoxybenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 2-methylbenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 2-nitrobenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-(3-methylphenyl)propanoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-(4-methylphenyl)propanoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-aminobenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-bromobenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-chlorobenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-fluorobenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-hydroxybenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-methylbenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-phenylpropanoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 4-aminobenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 4-bromobenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 4-chlorobenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 4-fluorobenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 4-hydroxybenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 4-methylbenzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 6-chloropyridine-3-carboxylate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 6-hydroxypyridine-3-carboxylate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl benzoate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl pyridine-3-carboxylate | - |
Staphylococcus aureus | |
| 6.1.1.1 | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl pyridine-4-carboxylate | - |
Staphylococcus aureus | |
| 6.1.1.1 | additional information | synthesis and evaluation of a series of novel 4-hydroxy-3-(naphthalen-1-ylmethyl)thiophen-2(5H)-ones as tyrosyl-tRNA synthetase inhibitors, molecular docking, structure-activity relationships, overview | Staphylococcus aureus |
Organism
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 6.1.1.1 | Staphylococcus aureus | - |
- |
- |
| 6.1.1.1 | Staphylococcus aureus ATCC 25923 | - |
- |
- |
Temperature Optimum [°C]
| EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
|---|---|---|---|---|
| 6.1.1.1 | 37 | - |
assay at | Staphylococcus aureus |
pH Optimum
| EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
|---|---|---|---|---|
| 6.1.1.1 | 7.9 | - |
assay at | Staphylococcus aureus |
IC50 Value
| EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
|---|---|---|---|---|---|---|
| 6.1.1.1 | 0.0111 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-(4-methylphenyl)propanoate | |
| 6.1.1.1 | 0.01898 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-(3-methylphenyl)propanoate | |
| 6.1.1.1 | 0.04332 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl benzoate | |
| 6.1.1.1 | 0.04476 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 4-hydroxybenzoate | |
| 6.1.1.1 | 0.04894 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 4-aminobenzoate | |
| 6.1.1.1 | 0.05008 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 4-methylbenzoate | |
| 6.1.1.1 | 0.05117 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 4-bromobenzoate | |
| 6.1.1.1 | 0.05523 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 4-chlorobenzoate | |
| 6.1.1.1 | 0.06514 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 4-fluorobenzoate | |
| 6.1.1.1 | 0.069 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-methylbenzoate | |
| 6.1.1.1 | 0.07109 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-aminobenzoate | |
| 6.1.1.1 | 0.07211 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-hydroxybenzoate | |
| 6.1.1.1 | 0.08214 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-fluorobenzoate | |
| 6.1.1.1 | 0.083 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-phenylpropanoate | |
| 6.1.1.1 | 0.08313 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-bromobenzoate | |
| 6.1.1.1 | 0.08613 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 3-chlorobenzoate | |
| 6.1.1.1 | 0.08862 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 2-methylbenzoate | |
| 6.1.1.1 | 0.0921 | - |
pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 2-methoxybenzoate | |
| 6.1.1.1 | 0.1 | - |
above, pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 2-bromobenzoate | |
| 6.1.1.1 | 0.1 | - |
above, pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 2-chlorobenzoate | |
| 6.1.1.1 | 0.1 | - |
above, pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 2-chloropyridine-3-carboxylate | |
| 6.1.1.1 | 0.1 | - |
above, pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 2-fluorobenzoate | |
| 6.1.1.1 | 0.1 | - |
above, pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 2-nitrobenzoate | |
| 6.1.1.1 | 0.1 | - |
above, pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 6-chloropyridine-3-carboxylate | |
| 6.1.1.1 | 0.1 | - |
above, pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl 6-hydroxypyridine-3-carboxylate | |
| 6.1.1.1 | 0.1 | - |
above, pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl pyridine-3-carboxylate | |
| 6.1.1.1 | 0.1 | - |
above, pH 7.9, 37°C, recombinant enzyme | Staphylococcus aureus | 4-[(naphthalen-1-yl)methyl]-5-oxo-2,5-dihydrothiophen-3-yl pyridine-4-carboxylate | |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
